Plazmatrit is a manufacturing startup specializing in advanced medical devices utilizing X-ray, alpha, beta, and gamma radiation. Founded in 2015, Plazmatrit aims to provide superior healthcare solutions through innovative technology. The company recently secured a significant $1.73M Series C investment on October 19, 2020. This funding will undoubtedly bolster their efforts to further develop their cutting-edge medical devices. As the industry continues to demand innovative solutions, Plazmatrit's focus on leveraging radiation for medical purposes positions them at the forefront of transformative healthcare technology.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series C | $1.73M | - | 19 Oct 2020 | |
Grant | $1.25M | - | 01 Feb 2018 | |
Series A | $1.14M | - | 05 Aug 2016 |
No recent news or press coverage available for Plazmatrit.